Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Thomas John C | 0001424620 | Dec-16-2020 | director |
Whitley Richard James | 0001441661 | Dec-16-2020 | director |
De La Rosa Abel | 0001825983 | Dec-16-2020 | director |
Keefer David R | 0001825986 | Dec-16-2020 | director |
Walsh Angela | 0001825987 | Dec-16-2020 | officer: VP of Finance |
Grosswald Ralph | 0001826084 | Dec-16-2020 | officer: Vice President of Operations |
Pridgen William | 0001826115 | Dec-16-2020 | director |
Gendreau Roger Michael | 0001826131 | Dec-16-2020 | officer: Chief Medical Officer |
Duncan Gregory Scott | 0001831127 | Dec-16-2020 | director, officer: Chief Executive Officer |
Burch Richard Alan | 0001837084 | Dec-16-2020 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Virios Therapeutics, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
DEF 14A | Document | Definitive proxy statements Acc-no: 0001558370-24-005761 (34 Act) Size: 791 KB |
Apr-25-2024 | 24876939 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001558370-24-002828 (34 Act) Size: 5267 KB |
Mar-08-2024 | 24735333 |
8-K | Document | Current report filing Acc-no: 0001558370-24-002613 (34 Act) Size: 171 KB |
Mar-06-2024 | 24726353 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001558370-24-002239 (34 Act) Size: 5331 KB |
Mar-01-2024 | 24707222 |
8-K | Document | Current report filing Acc-no: 0001558370-24-002113 (34 Act) Size: 288 KB |
Feb-29-2024 | 24699281 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005686 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005684 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005681 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005679 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005676 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005674 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005672 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005670 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005668 ( Act) Size: 5 KB |
Feb-28-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-005666 ( Act) Size: 5 KB |
Feb-28-2024 | |
DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0001558370-24-001844 (34 Act) Size: 39 KB |
Feb-27-2024 | 24687109 |
8-K | Document | Current report filing Acc-no: 0001558370-24-001840 (34 Act) Size: 165 KB |
Feb-27-2024 | 24686925 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001654954-24-001683 (34 Act) Size: 33 KB |
Feb-13-2024 | 24630614 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0001558370-24-000721 (34 Act) Size: 543 KB |
Feb-02-2024 | 24591996 |
PRE 14A | Document | Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001558370-24-000398 (34 Act) Size: 542 KB |
Jan-22-2024 | 24547288 |
Recent 20 filings. View all Virios Therapeutics, Inc. filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by